
Tesamorelin/Ipamorelin
Ships fully reconstituted · no mixing, no powder, no bacteriostatic waterAdvanced Metabolic & GH Combo
Dual-pathway GH combo targeting visceral fat and lean body composition.
Choose your supply
Frequently paired with
What it supports
- Targeted visceral fat reduction
- Enhanced lean muscle mass
- Improved metabolic function
- Better sleep quality
- Increased energy and recovery
- Clean GH release profile
- Supports healthy lipid levels
The details
- Administration
- Subcutaneous injection
- Format
- 2mg/mL (Tesamorelin) + 1mg/mL (Ipamorelin), 5mL vial
- Typical dosing
- Per provider guidance, subcutaneous injection daily
- Best for
- Visceral fat reduction, body composition, lean mass
- Pairs well with
- MOTS-C, AOD 9604
How it works
Signal
Tesamorelin/Ipamorelin is given as a single daily subcutaneous injection on a provider-determined schedule.
Cellular response
Tesamorelin activates GHRH receptors for sustained GH release and targeted lipolysis in visceral fat, while Ipamorelin selectively triggers ghrelin-pathway GH secretion. Together they amplify fat-burning and muscle-sparing effects without cortisol or prolactin spikes.
Outcome
Over the following weeks most people notice better sleep and a small energy lift first (weeks 1–2), then a looser waistband and faster recovery (weeks 2–4), then measurable belly-fat reduction and visible body-composition change (weeks 4–8), with the strongest results from week 8 onward.
Research highlights
Tesamorelin FDA-approved for visceral fat reduction
Ipamorelin well-studied for selective GH release
Complementary mechanisms maximize body composition benefits
Strong safety profiles for both compounds
Research summaries are provided for educational context and are not a promise of results. Talk with your provider about what to expect.
Sources & references
Visceral fat reduction with Tesamorelin
Falutz J et al. N Engl J Med. 2010;362(9):846–858.
View sourceIpamorelin: selective GH release
Raun K et al. Eur J Endocrinol. 1999;141(2):180–189.
View sourceTesamorelin metabolic benefits over 12 months
Stanley TL et al. J Clin Endocrinol Metab. 2012;97(3):983–991.
View source
Common questions
Important safety information
Tesamorelin/Ipamorelin is available by prescription only and is dispensed after a licensed provider reviews your medical screening and determines it is appropriate for you. Compounded medications are prepared by a licensed U.S. pharmacy and are not FDA-approved products. Tell your provider about your full medical history and any medications you take.
- • Generally well tolerated
- • Possible injection site reactions
- • Should not be used with active cancer
- • Requires licensed provider supervision


